Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancer
Qian Zhou(Jinan University), Liang Chen(Henan Medical University), Zhenzhen Fan(Jinan University), Ye‐Guang Chen(First Affiliated Hospital of Jiangxi Medical College), Biao Yu(Chinese Academy of Sciences), Jinxia Liang(Jinan University), Meng Xu(First Affiliated Hospital of Jinan University), Zhipeng Chen(University of Science and Technology of China), Lu Liu(Nanchang University), Xin Cao, Wensheng Chen(Texas A&M University), Wanting Liu(Jinan University), Tong Yang(Jinan University), Guandi Zeng(Jinan University)
Cited by 30
Related Papers
Controlling TGF-β signaling
|Genes & Development|2000|1.6k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
TGF-β Signaling from Receptors to Smads
|Cold Spring Harbor Perspectives in Biology|2016|868
Dishevelled: The hub of Wnt signaling
|Cellular Signalling|2009|751